2021 annual financial data
Stoke Therapeutics 2021 Operating margin
Direct answer
Operating margin was -2,868.83%.
Operating income was -86,065,000 USD and net income was -84,711,000 USD.
Operating cash flow was -66,907,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -86,065,000 USD
- Net income
- -84,711,000 USD
- Operating cash flow
- -66,907,000 USD